G. Rosen, M. Murphy, A. Huvos, M. Gutierrez, and R. Marcove, Chemotherapy,en bloc resection, and prosthetic bone replacement in the treatment of osteogenic sarcoma, Cancer, vol.32, issue.1, pp.1-11, 1976.
DOI : 10.1002/1097-0142(197601)37:1<1::AID-CNCR2820370102>3.0.CO;2-3

M. Link, A. Goorin, M. Horowitz, W. Meyer, J. Belasco et al., Adjuvant chemotherapy of high-grade osteosarcoma of the extremity. Updated results of the multiinstitutional osteosarcoma study, Clin Orthop, vol.270, pp.8-14, 1991.

A. Provisor, L. Ettinger, J. Nachman, M. Krailo, J. Makley et al., Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: a report from the Children's Cancer Group., Journal of Clinical Oncology, vol.15, issue.1, pp.76-84, 1997.
DOI : 10.1200/JCO.1997.15.1.76

S. Rosenberg, P. Spiess, and R. Lafreniere, A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes, Science, vol.233, issue.4770, pp.1318-1321, 1986.
DOI : 10.1126/science.3489291

P. Aebersold, C. Hyatt, S. Johnson, K. Hines, L. Korcak et al., Lysis of Autologous Melanoma Cells by Tumor*Infiltrating Lymphocytes: Association With Clinical Response, JNCI Journal of the National Cancer Institute, vol.83, issue.13, pp.932-937, 1991.
DOI : 10.1093/jnci/83.13.932

S. Rosenberg, Progress in human tumour immunology and immunotherapy, Nature, vol.411, issue.6835, pp.380-384, 2001.
DOI : 10.1038/35077246

M. Dudley, J. Wunderlich, T. Shelton, J. Even, and S. Rosenberg, Generation of Tumor-Infiltrating Lymphocyte Cultures for Use in Adoptive Transfer Therapy for Melanoma Patients, Journal of Immunotherapy, vol.26, issue.4, pp.332-342, 2003.
DOI : 10.1097/00002371-200307000-00005

M. Fabbri, R. Ridolfi, R. Maltino, L. Ridolfi, A. Riccobon et al., Tumor infiltrating lymphocytes and continous infusion interleukin-2 after metastasectomy in 61 patients with melanoma, colorectal and renal carcinoma, Tumori, vol.86, pp.46-52, 2000.

J. Huang, H. Khong, M. Dudley, M. El-gamil, Y. Li et al., Survival, Persistence, and Progressive Differentiation of Adoptively Transferred Tumor-Reactive T Cells Associated with Tumor Regression, Journal of Immunotherapy, vol.28, issue.3, pp.258-267, 2005.
DOI : 10.1097/01.cji.0000158855.92792.7a

E. Hage, F. Vergnon, I. Grunenwald, D. Soria, J. Chouaib et al., Generation of diverse mutated tumor antigen-specific cytotoxic T lymphocytes in a lung cancer patient with long survival, Oncol Rep, vol.14, pp.763-769, 2005.

R. Dillma, P. Schiltz, C. Depriest, N. Barth, L. Beutel et al., Tumor-Infiltrating Lymphocytes and Interleukin-2: Dose and Schedules of Administration in the Treatment of Metastatic Cancer, Cancer Biotherapy & Radiopharmaceuticals, vol.19, issue.6, pp.730-737, 2004.
DOI : 10.1089/cbr.2004.19.730

D. Kowalczyk, W. Skorupski, Z. Kwias, and J. Nowak, Flow cytometric analysis of tumour-infiltrating lymphocytes in patients with renal cell carcinoma, BJU International, vol.80, issue.4, pp.543-547, 1997.
DOI : 10.1046/j.1464-410X.1997.00408.x

A. Dierderichsen, J. Zeuthen, P. Christensen, and T. Kristensen, Characterisation of tumour infiltrating lymphocytes and correlations with immunological surface molecules in colorectal cancer, European Journal of Cancer, vol.35, issue.5, pp.721-726, 1999.
DOI : 10.1016/S0959-8049(99)00033-7

M. Ikeguchi, K. Oi, Y. Hirooka, and N. Kaibara, CD8+ lymphocyte infiltration and apoptosis in hepatocellular carcinoma, European Journal of Surgical Oncology (EJSO), vol.30, issue.1, pp.53-57, 2004.
DOI : 10.1016/j.ejso.2003.10.001

E. Yakirevich, O. Izhak, G. Rennert, Z. Kovacs, and M. Resnick, Cytotoxic phenotype of tumor infiltrating lymphocytes in medullary carcinoma of the breast, Mod Pathol, vol.12, pp.1050-1056, 1999.

M. Mercader, B. Bodner, M. Moser, P. Kwon, E. Park et al., T cell infiltration of the prostate induced by androgen withdrawal in patients with prostate cancer, Proceedings of the National Academy of Sciences, vol.12, issue.5
DOI : 10.1016/S0952-7915(00)00147-3

T. Sudo, T. Kuramoto, S. Komiya, A. Inoue, and K. Itoh, Expression of MAGE genes in osteosarcoma, Journal of Orthopaedic Research, vol.64, issue.1, pp.128-132, 1997.
DOI : 10.1002/jor.1100150119

H. Ishida, S. Komiya, Y. Inoue, S. Yutani, A. Inoue et al., Expression of the SART1 tumor-rejection antigen in human osteosarcomas., International Journal of Oncology, vol.17, pp.29-32, 2000.
DOI : 10.3892/ijo.17.1.29

N. Tsuda, K. Murayama, H. Ishida, K. Matsunaga, S. Komiya et al., Expression of a newly defined tumor-rejection antigen SART3 in musculoskeletal tumors and induction of HLA class I-restricted cytotoxic T lymphocytes by SART3-derived peptides, Journal of Orthopaedic Research, vol.88, issue.3, pp.346-351, 2001.
DOI : 10.1016/S0736-0266(00)90031-7

T. Tsukahara, Y. Nabeta, S. Kawaguchi, H. Ikeda, Y. Sato et al., Identification of Human Autologous Cytotoxic T-Lymphocyte-Defined Osteosarcoma Gene That Encodes a Transcriptional Regulator, Papillomavirus Binding Factor, Cancer Research, vol.64, issue.15, pp.5442-5448, 2004.
DOI : 10.1158/0008-5472.CAN-04-0522

Y. Miyagi, N. Imai, T. Sasatomi, A. Yamada, T. Mine et al., Induction of cellular immune responses to tumor cells and peptides in colorectal cancer patients by vaccination with SART3 peptides, Clin Cancer Res, vol.7, pp.3950-3962, 2001.

K. Trieb, S. Lang, and R. Kotz, HEAT-SHOCK PROTEIN 72 IN HUMAN OSTEOSARCOMA: T-Lymphocyte Reactivity and Cytotoxicity, Pediatric Hematology and Oncology, vol.87, issue.5, pp.355-364, 2000.
DOI : 10.1080/08880010050034283